All for Joomla All for Webmasters

Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus

Rate this item
(0 votes)

Utility:

The clinical performance of the QUANTA Flash CTD Screen Plus was evaluated and compared with both manual and automated IFA. The CTD CIA showed 78.1 % sensitivity for SARD, coupled with 94.1 % specificity. Manual IFA and NOVA View showed somewhat higher sensitivity (81.5 and 84.8 % in SARD, respectively), but significantly lower specificity (79.4 and 64.7 %, respectively). With the added benefits of full automation, the new CTD CIA is an attractive alternative to traditional ANA screening
Read 283 times

Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service

No Internet Connection